AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 159 filers reported holding AERIE PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 9.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $118,000 | -56.5% | 10,100 | -45.1% | 0.16% | -83.5% |
| Q2 2020 | $271,000 | -53.6% | 18,400 | -57.5% | 0.99% | +220.3% |
| Q1 2020 | $584,000 | -44.2% | 43,300 | 0.0% | 0.31% | +152.0% |
| Q4 2019 | $1,046,000 | -8.8% | 43,300 | -27.5% | 0.12% | -16.3% |
| Q3 2019 | $1,147,000 | -67.9% | 59,700 | -50.6% | 0.15% | -40.7% |
| Q2 2019 | $3,572,000 | -52.2% | 120,900 | -23.1% | 0.25% | -28.3% |
| Q1 2019 | $7,467,000 | +31.6% | 157,200 | 0.0% | 0.35% | -11.5% |
| Q4 2018 | $5,674,000 | +188.3% | 157,200 | -2.9% | 0.39% | +96.5% |
| Q1 2016 | $1,968,000 | – | 161,900 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 246,563 | $2,244,000 | 1.36% |
| LEVIN CAPITAL STRATEGIES, L.P. | 1,435,876 | $13,066,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,695,020 | $42,725,000 | 0.96% |
| DCF Advisers, LLC | 189,565 | $1,725,000 | 0.76% |
| DAFNA Capital Management LLC | 289,040 | $2,630,000 | 0.68% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,678,609 | $15,275,000 | 0.61% |
| Rhenman & Partners Asset Management AB | 589,200 | $5,362,000 | 0.53% |
| PFM Health Sciences, LP | 1,088,566 | $9,906,000 | 0.37% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $2,819,000 | 0.36% |
| Granahan Investment Management | 1,588,944 | $14,459,000 | 0.36% |